Category Archives: MS Treatment

Medicinal cannabis can significantly benefit the treatment of nerve pain underlying conditions such as multiple sclerosis and diabetes, according to a review of existing evidence on its clinical effectiveness and safety. The finding by the Health Research Board (HRB) is likely to see the existing Medicinal Cannabis Access Programme expanded to include the treatment of neuropathic or nerve pain conditions. The study found evidence to support the prescribing of medicinal cannabis for conditions for which it is already approved in Ireland such as nausea and vomiting in cancer and spasticity in multiple sclerosis Continue reading →

Research scientist Cristina A. Continue reading →

MS Actress Christina Applegate is back in the news about her struggle with multiple sclerosis (MS). After staying out the public eye since her diagnosis, Applegate got a standing ovation at this week's Emmy Awards Continue reading →

The first rule of thumb is to be open and descriptive when speaking to your doctor. These strategies can help you communicate more effectively with your MS care team. You may not want to disappoint your doctor by telling them that you havent stuck to your treatment regimen, but its very important to share this information Continue reading →

In the last 15 years, the therapeutic options for multiple sclerosis (MS) have changed dramatically. Several drugs have been approved that reduce the risk of relapse and show a decrease in disability progression Continue reading →

Jennifer Cox and daughter Chloe Wilcox Courtesy photo McCOOK, Neb. Continue reading →

Following the recent FDA approval for vonoprazan (Voquenza) in the treatment of gastroesophageal reflux disease, Colin Howden, MD, professor of medicine at the University of Tennessee Health Science Center, joined for an interview to discuss the inner workings of the drug, patient monitoring, and potential future uses. Continue reading →

Enrollment is nearly complete in a clinical trial of the Sconeneuromodulation device in treating neurogenic, or overactive, bladder due to multiple sclerosis (MS), stroke, or spinal cord injury, SpineX, its developer, announced. Currently, 95 adult patients (more than 80% of planned total), ages 18 to 75, are taking part in the CONTINENCE study (NCT05301335) at sites in the U.S., Canada, and India Continue reading →

Higher blood levels of macrophage migration inhibitory factor (MIF), a molecule involved in inflammation, may predict a faster rate of brain shrinkage, or atrophy, in people with primary progressive multiple sclerosis (PPMS). Thats according to a new analysis of data from the SPRINT-MS Phase 2 trial (NCT01982942) that investigated ibudilast, an experimental oral MS therapy aiming to reduce inflammation in people with progressive forms of multiple sclerosis (MS). While previous trial data showed that ibudilast significantly slowed brain atrophy, the treatment had no effect on MIF levels over its two years. Continue reading →

Unveiling the Link Between Vitamin B and Multiple Sclerosis Recent scientific advancements have shed light on a potential molecular link between vitamin B and multiple sclerosis (MS), a neurodegenerative condition that affects millions worldwide. Continue reading →